CDK4/6 Inhibition in the Metastatic Setting: Where Are We Headed? Elizabeth SakachMerve KeskinkilicKevin Kalinsky ReviewPaper 14 June 2023 Pages: 1103 - 1119
Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy? Naomi DempseyAna SandovalReshma Mahtani ReviewPaper 10 July 2023 Pages: 1120 - 1137
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading? Juan Jose Juarez-Vignon WhaleyMichelle AfkhamiVictoria M. Villaflor ReviewPaper Open access 15 June 2023 Pages: 1138 - 1166
Antibody Drug Conjugates in Bladder Cancer: Current Milestones and Future Perspectives Raafat AlameddinePatrick MalleaYousef Zakharia ReviewPaper 05 July 2023 Pages: 1167 - 1182
Targeting HIF-2 Alpha in Renal Cell Carcinoma Ramsha AhmedMoshe C. Ornstein ReviewPaper 05 July 2023 Pages: 1183 - 1198
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials Benjamin L. MaughanDeepika Sirohi ReviewPaper 06 July 2023 Pages: 1199 - 1212
Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer Amisha SinghAppledene S. OsbourneVadim S. Koshkin ReviewPaper 10 July 2023 Pages: 1213 - 1230
The Evolving Treatment Landscape of Merkel Cell Carcinoma Neha SinghErin M. McClurePaul Nghiem ReviewPaper 05 July 2023 Pages: 1231 - 1258
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review Prioty Islam ReviewPaper 06 July 2023 Pages: 1259 - 1273
Enhanced Photodynamic Therapy by Improved Light Energy Capture Efficiency of Porphyrin Photosensitizers Zejie TianHui LiYunmei Liu ReviewPaper 06 July 2023 Pages: 1274 - 1292
Management of Thromboembolic Disease in Patients with Primary and Metastatic Brain Tumors Ryan R. WoodsGlenn J. Lesser ReviewPaper Open access 06 July 2023 Pages: 1293 - 1303
